JPM22, Day 3: BeiGene, Ionis promise 'tidal wave' of new drugs; Roche launches smart, point-of-care glucose monitor

We're off for another day of the J.P. Morgan Healthcare Conference. We saw a clamor of research collaboration announcements that defined the first two days of the conference. Now, those announcements have slowed, but there's plenty of action to come as companies make their pitches to their peers, investors and industry watchers.

And we're still holding out hope for a JPM-defining blockbuster M&A deal. If that happens, you'll hear about it right here.